drugset / Trial / NCT01902459

EVARREST™ Fibrin Sealant Patch Post-Market Study

NCT01902459 ↗

Phase 4 Completed 150 enrolled Ethicon, Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

The objective of this study is to evaluate the clinical utility of EVARREST™ Fibrin Sealant Patch (Fibrin Pad) as an adjunct to hemostasis in soft tissue bleeding during intra-abdominal (stomach area), retroperitoneal (hip and stomach area), pelvic (hip area) and non-cardiac thoracic (chest area) surgery.

Timeline

Start
2013-07-01
Primary completion
2015-08-01
Completion
2015-09-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fibrin Pad Protein / enzyme biologic — —

Indications